Brief: FibroBiologics Advancing Development Of A Fibroblast Treatment For Hantavirus
11/05/2026 14:11
May 11 (Reuters) - Fibrobiologics Inc FBLG.O: FIBROBIOLOGICS ADVANCING DEVELOPMENT OF A FIBROBLAST TREATMENT FOR HANTAVIRUS FIBROBIOLOGICS INC - TO INITIATE DISCUSSIONS WITH REGULATORS FOR HPS CLINICAL EVALUATION Source text: ID:nGNX9RZMkc Further company coverage: FBLG.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fibrobiologics
See all newsBrief: Fibrobiologics Files Patent Application For Technology Designed To Produce Glp-1 And Other Therapeutic Peptides Inside The Body
Brief: Fibrobiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair In Preclinical Study Of Degenerative Joints
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Brief: Fibrobiologics Granted US Patent Covering The Use Of Fibroblasts